PTC Therapeutics Stock Performance
as on August 19, 2026 at 6:59 am IST
Day's Low
Day's High
$72.22$74.03
0.62%
Downside
1.87%
Upside
52 Week's Low
52 Week's High
$47.94$90.8734.04%
Downside
25.04%
Upside
PTC Therapeutics share price movements today
- Previous Close
- $72.88
- Open
- $72.86
- Volume
- 663.8K
- Market Cap
- $6.0B
- Day's Low - High
- $72.22 - $74.03
- 52 Week Low - High
- $47.94 - $90.87
PTC Therapeutics Historical Returns
- 1 Month Return
- -8.77 %
- 3 Month Return
- + 0.32 %
- 1 Year Return
- + 46.87 %
- 3 Year Return
- + 79.25 %
- 5 Year Return
- + 82.77 %
PTC Therapeutics Stock Fundamentals & Key Indicators
Check PTC Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.0B
EPS (TTM)
-0.49
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-146.88
Industry PE ratio
-13.046547619047619
PEG Ratio
0.9663313857126116
EBITDA
173.5M
Revenue (TTM)
1.0B
Profit Margin
82.14%
Return On Equity TTM
21.72%
PTC Therapeutics Stock Valuation
Track how PTC Therapeutics P/E has moved over time to understand its valuation trends.
PTC Therapeutics in the last 5 years
Lowest (-9.54x)
December 31, 2024
Industry (-13.05x)
December 31, 2025
Today (8.85x)
December 31, 2025
Highest (8.85x)
December 31, 2025
Today’s Price to Earnings Ratio: 8.85x
PTC Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of PTC Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $6.0B | 82.77% | -146.88 | 82.14% | NA | |
| BUY | $43.7B | 669.3% | NA | 0.00% | NA | |
| BUY | $128.2B | 154.86% | 29.82 | 86.04% | NA | |
| BUY | $82.7B | 24.1% | 19.24 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for PTC Therapeutics Stock including INR - Dollar returns
The PTC Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
PTC Therapeutics investment value today
Current value as on today
₹1,63,104
Returns
₹63,104
(+63.1%)
Returns from PTC Therapeutics Stock
₹48,853 (+48.85%)
Dollar Impact
₹14,251 (+14.25%)
Analyst Recommendation on PTC Therapeutics Stock
Based on 11 analysts
81.82%
Buy
9.09%
Hold
9.09%
Sell
Based on 11 analysts, 81.81818181818183% of analysts recommend a 'BUY' rating for PTC Therapeutics. Average target price of $99.29
PTC Therapeutics Share Price Target
Get share price movements and forecasts by analysts on PTC Therapeutics.
What analysts predicted
26.81%UPSIDE
Target Price
$99.29
Current Price
$72.67
Analyzed by
11 Analysts
Target
$99.29
PTC Therapeutics target price $99.29, a slight upside of 26.81% compared to current price of $72.67. According to 11 analysts rating.
Indian Investors' Interest in PTC Therapeutics Stock
Search interest for PTC Therapeutics Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
PTC Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
PTC Therapeutics Annual Profit & Loss
All numbers in Millions USD
PTC Therapeutics Quarterly Cash Flow
All numbers in Millions USD
PTC Therapeutics Annual Cash Flow
All numbers in Millions USD
PTC Therapeutics News & Key Events
Today's Timeline - 30 July
Fri, 01:36 AM
-PTC Therapeutics raises 2026 revenue guidance after strong Q2 performance and appoints Hege Sollie-Zetlmayer to the board.
Fri, 02:55 AM
-PTC Therapeutics beats Q2 earnings estimates with $0.92 per share, surprising analysts significantly.
Fri, 06:34 AM
-PTC Therapeutics director details stock options and RSUs, affecting employee share ownership and potential dilution.
Insights on PTC Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 164.67M → 360.51M (in $), with an average increase of 32.0% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -134.96M → 83.49M (in $), with an average increase of 2404.1% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 480.2% return, outperforming this stock by 433.2%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.7% return, outperforming this stock by 530.8%
NEGATIVE IMPACTPrice Dip
In the last 1 month, PTCT stock has moved down by -7.3%
About PTC Therapeutics
| Organisation | PTC Therapeutics |
| Headquarters | 500 Warren Corporate Center Drive, Warren, NJ, United States, 07059 |
| Industry | Biotechnology |
| CEO | Dr. Matthew B. Klein F.A.C.S., M.D., M.S. |
| E-voting on shares | Click here to vote |
Key Management of PTC Therapeutics
Name | Title |
|---|---|
Dr. Matthew B. Klein F.A.C.S., M.D., M.S. | CEO & Director |
Dr. Allan Steven Jacobson Ph.D. | Co-Founder & Independent Director |
Dr. Lee Scott Golden M.D., Ph.D. | Executive VP & Chief Medical Officer |
Ms. Christine Utter CPA | Senior VP, Chief Accounting Officer & Head of People Services |
Ms. Ellen Cavaleri | Head of Investor Relations |
Mr. Pierre Gravier M.S. | Chief Financial Officer |
Dr. Neil Almstead Ph.D. | Chief Technical Operations Officer |
Mr. Eric Pauwels | Chief Business Officer |
Ms. Linda Montella Carter | Senior VP & Chief Information Officer |
Mr. Mark Elliott Boulding J.D. | Executive VP & Chief Legal Officer |
FAQs
What is PTC Therapeutics share price today?
PTC Therapeutics share price today is $72.67 as on at the close of the market. PTC Therapeutics share today touched a day high of $74.03 and a low of $72.22.
What is the 52 week high and 52 week low for PTC Therapeutics share?
PTC Therapeutics share touched a 52 week high of $90.87 on and a 52 week low of $47.94 on . PTC Therapeutics stock price today i.e. is closed at $72.67,which is 20.03% down from its 52 week high and 51.60% up from its 52 week low.
What is PTC Therapeutics's market capitalisation today?
PTC Therapeutics market capitalisation is $0.01T as on .
How to invest in PTC Therapeutics Stock (PTCT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for PTC Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PTC Therapeutics Shares that will get you 0.0206 shares as per PTC Therapeutics share price of $72.67 per share as on August 19, 2026 at 1:29 am IST.
What is the minimum amount required to buy PTC Therapeutics Stock (PTCT) from India?
Indian investors can start investing in PTC Therapeutics (PTCT) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in PTC Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on PTC Therapeutics share’s latest price of $72.67 as on August 19, 2026 at 1:29 am IST, you will get 0.1376 shares of PTC Therapeutics. Learn more about
fractional shares .
What are the returns that PTC Therapeutics has given to Indian investors in the last 5 years?
PTC Therapeutics stock has given 82.77% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?